Parallel49 Equity is a prominent private equity firm specializing in investments in profitable and well-managed lower middle-market companies in the United States and Canada. With a track record dating back to 1996, the firm and its predecessor have successfully managed over C$1.2 billion of investor capital, demonstrating their expertise in the field. Currently managing their fifth fund with over $300 million of committed capital, Parallel49 Equity is recognized for their strategic approach and commitment to delivering value to their portfolio companies.
Parallel49 Equity's portfolio includes a diverse range of businesses, and their investment strategy focuses on partnering with companies that have strong growth potential and a solid management team. With a reputation for precision and excellence, Parallel49 Equity has established itself as a trusted partner for businesses seeking capital and strategic guidance. Their recent sale of MedTorque to ARCH Medical Solutions Corp further highlights their successful track record and ability to generate value for their investors.
Generated from the website